🇺🇸 FDA
Patent

US 8742109

Synthetic methods for spiro-oxindole compounds

granted A61PA61P25/00A61P25/04

Quick answer

US patent 8742109 (Synthetic methods for spiro-oxindole compounds) held by Xenon Pharmaceuticals Inc. expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P25/00, A61P25/04